Standout Papers
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2014)
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults (2009)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure (2017)
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2014)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America (2017)
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons (2019)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary (2014)
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2019)
- COVID-19 and African Americans (2020)
- Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure (2004)
- 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults (2009)
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults (2009)
- Social Determinants of Risk and Outcomes for Cardiovascular Disease (2015)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
- Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure (2007)
- Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association (2017)
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure (2006)
- Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function (2005)
- Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction (2014)
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America (2016)
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction (2017)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary (2011)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure (2017)
- 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction (2021)
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association (2016)
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure (2016)
- Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond (2011)
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary (2014)
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association (2017)
- Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association (2016)
- 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope (2017)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society (2017)
- 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation (2019)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society (2017)
- 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (2023)
- Recalibrating the Use of Race in Medical Research (2021)
- Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020 (2023)
- 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction (2024)
Immediate Impact
4 from Science/Nature 131 standout
Citing Papers
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
2023 Standout
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
2023 Standout
Works of Clyde W. Yancy being referenced
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Clyde W. Yancy | 47166 | 7255 | 2756 | 5455 | 594 | 58.5k | |
| Christian Torp‐Pedersen | 31274 | 6954 | 1568 | 4153 | 1.3k | 50.3k | |
| Adrian F. Hernandez | 25386 | 6082 | 2549 | 5307 | 884 | 40.6k | |
| Christopher B. Granger | 48225 | 13453 | 2559 | 4722 | 833 | 62.0k | |
| Aldo P. Maggioni | 34479 | 7671 | 1499 | 5216 | 859 | 47.2k | |
| John G.F. Cleland | 46702 | 6996 | 2127 | 7247 | 1.3k | 66.6k | |
| Paul A. Heidenreich | 25166 | 5516 | 2954 | 3132 | 597 | 34.5k | |
| Christopher M. O’Connor | 32355 | 6326 | 1125 | 5874 | 650 | 40.2k | |
| Joseph M. Massaro | 22006 | 11083 | 1558 | 5937 | 404 | 46.0k | |
| Lars Køber | 38013 | 10184 | 1453 | 5442 | 1.3k | 57.2k | |
| David A. Morrow | 28608 | 12434 | 973 | 3197 | 579 | 42.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...